X0201 4/A 2003-05-23 2003-05-27 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001181162 STAUB W RICHARD 3210 MERRIMAN AVENUE RALEIGH NC 27607 0 1 0 0 Sr. Vice President Stock options (to buy) 10.25 2003-05-23 4 M 0 3334 0 D 2003-02-28 2010-02-28 Common Stock 3334 43500 D Stock Options (to buy) 11.7188 2003-05-23 4 M 0 1000 0 D 2003-03-01 2010-03-01 Common Stock 1000 42500 D This report is being filed to amend Column 9 on lines two and three in Table II of the Form 4 originally filed on May 27, 2003. The original report stated the amount of derivative securities beneficially owned following the reported transactions to be 29,500 and 28,500, respectively; the report should have stated that the Reporting Person owned 43,500 and 42,500 options, respectively, following the reported transactions. Lisa C. Noecker for W. Richard Staub 2004-02-18